1. Cognitive Impairment and MS: Searching for Effective Therapies

   • Vijayshree Yadav
   • Dennis N. Bourdette

   Clinical Trial Report 30 July 2011 Pages: 451 - 454

2. Role of Cerebrospinal Fluid and Plasma Biomarkers in the Diagnosis of Neurodegenerative Disorders and Mild Cognitive Impairment

   • Luis F. Gonzalez-Cuyar
   • Joshua A. Sonnen
   • Thomas J. Montine

   ReviewPaper 05 July 2011 Pages: 455 - 463

3. Advances in Epigenetics and Epigenomics for Neurodegenerative Diseases

   • Irfan A. Qureshi
   • Mark F. Mehler

   ReviewPaper 15 June 2011 Pages: 464 - 473

4. Cognitive Impairment in Huntington Disease: Diagnosis and Treatment

   • Jane S. Paulsen

   ReviewPaper 23 August 2011 Pages: 474 - 483

5. Pharmacogenomics and Multiple Sclerosis: Moving Toward Individualized Medicine

   • Manuel Comabella
   • Koen Vandenbroeck

   ReviewPaper 24 June 2011 Pages: 484 - 491

6. Fingolimod for Multiple Sclerosis: Mechanism of Action, Clinical Outcomes, and Future Directions

   • Matthias Mehling
   • Ludwig Kappos
   • Tobias Derfuss

   ReviewPaper 26 July 2011 Pages: 492 - 497

7. The Radiologically Isolated Syndrome: Look (Again) Before You Treat

   • Rebecca Spain
   • Dennis Bourdette

   ReviewPaper 12 July 2011 Pages: 498 - 506

   

8. Gait Abnormalities in Multiple Sclerosis: Pathogenesis, Evaluation, and Advances in Treatment

   • Michelle H. Cameron
   • Joanne M. Wagner

   ReviewPaper 22 July 2011 Pages: 507 - 515